Increased GABA concentrations in type 2 diabetes mellitus are related to lower cognitive functioning
Authors:
- Frank C.G. van BusselFBFrank C.G. van Bussel
- Miranda T. SchramMSMiranda T. Schram
- Jacobus F.A. JansenJJJacobus F.A. Jansen
Open Access
- 1 September 2016
- journal article
- research article
- Published by Wolters Kluwer Health in Medicine
- Vol. 95 (36) , e4803
Abstract
Type 2 diabetes mellitus is associated with accelerated cognitive decline. The underlying pathophysiological mechanisms still remain to be elucidated although it is known that insulin signaling modulates neurotransmitter activity, including inhibitory γ-aminobutyric acid (GABA) and excitatory glutamate (Glu) receptors. Therefore, we examined whether levels of GABA and Glu are related to diabetes status and cognitive performance. Forty-one participants with type 2 diabetes and 39 participants without type 2 diabetes underwent detailed cognitive assessments and 3-Tesla proton MR spectroscopy. The associations of neurotransmitters with type 2 diabetes and cognitive performance were examined using multivariate regression analyses controlling for age, sex, education, BMI, and percentage gray/white matter ratio in spectroscopic voxel. Analysis revealed higher GABA+ levels in participants with type 2 diabetes, in participants with higher fasting blood glucose levels and in participants with higher HbA1c levels, and higher GABA+ levels in participants with both high HbA1c levels and less cognitive performance. To conclude, participants with type 2 diabetes have alterations in the GABAergic neurotransmitter system, which are related to lower cognitive functioning, and hint at the involvement of an underlying metabolic mechanism.Keywords
This publication has 31 references indexed in Scilit:
- Altered Excitation-inhibition Balance in the Brain of Patients with Diabetic NeuropathyAcademic Radiology, 2012
- Brain insulin signaling: A key component of cognitive processes and a potential basis for cognitive impairment in type 2 diabetesNeurobiology of Learning and Memory, 2011
- Associations of age, gender and body mass with 1H MR‐observed brain metabolites and tissue distributionsNMR in Biomedicine, 2011
- Diabetes as a chronic metabolic stressor: Causes, consequences and clinical complicationsExperimental Neurology, 2011
- A 4 year follow-up study of cognitive functioning in patients with type 2 diabetes mellitusDiabetologia, 2009
- Adiposity, hyperinsulinemia, diabetes and Alzheimer's diseaseEuropean Journal of Pharmacology, 2008
- Measurement of Brain Metabolites in Patients with type 2 Diabetes and Major Depression Using Proton Magnetic Resonance SpectroscopyNeuropsychopharmacology, 2006
- Segmentation of brain MR images through a hidden Markov random field model and the expectation-maximization algorithmIEEE Transactions on Medical Imaging, 2001
- Homonuclear J‐refocused spectral editing technique for quantification of glutamine and glutamate by 1H NMR spectroscopyMagnetic Resonance in Medicine, 1995
- Estimation of metabolite concentrations from localized in vivo proton NMR spectraMagnetic Resonance in Medicine, 1993